Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes

ArticleAçık Erişim

Özet

We have investigated how diabetes affects the expression of adropin (ADR) in rat brain, cerebellum, kidneys, heart, liver, and pancreas tissues. The rats in the diabetic group were administered an intraperitoneal (i.p.) injection of a single dose of 60 mg/kg streptozotocin (STZ) dissolved in a 0.1 M phosphate-citrate buffer (pH 4.5). The rats were maintained in standard laboratory conditions in a temperature between 21 and 23 C and a relative humidity of 70 %, under a 12-h light/dark cycle. The animals were fed a standard commercial pellet diet. After 10 weeks, the animals were sacrified. ADR concentrations in the serum and tissue supernatants were measured by ELISA, and immunohistochemical staining was used to follow the expression of the hormones in the brain, cerebellum, kidneys, heart, liver, and pancreas tissues. The quantities were then compared. Increased ADR immunoreaction was seen in the brain, cerebellum, kidneys, heart, liver, and pancreas in the diabetes-induced rats compared to control subjects. ADR was detected in the brain (vascular area, pia mater, neuroglial cell, and neurons), cerebellum (neuroglial cells, Purkinje cells, vascular areas, and granular layer), kidneys (glomerulus, peritubular interstitial cells, and peritubular capillary endothelial cells), heart (endocardium, myocardium, and epicardium), liver (sinusoidal cells), and pancreas (serous acini). Its concentrations (based on mg/wet weight tissues) in these tissues were measured by using ELISA showed that the levels of ADR were higher in the diabetic rats compared to the control rats. Tissue ADR levels based on mg/wet weight tissues were as follows: Pancreas > liver > kidney > heart > brain > cerebellar tissues. Evidence is presented that shows ADR is expressed in various tissues in the rats and its levels increased in STZ-induced diabetes; however, this effect on the pathophysiology of the disorder remains to be understood. © 2013 Springer Science+Business Media New York.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/15807Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1007/s11010-013-1660-4Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorAydin, Suleyman
dc.contributor.authorKuloglu, Tuncay
dc.contributor.authorAydin, Suna
dc.contributor.authorEren, Mehmet Nesimi
dc.contributor.authorYilmaz, Musa
dc.contributor.authorKalayci, Mehmet
dc.contributor.authorSahin, Ibrahim
dc.contributor.authorKocaman, Nevin
dc.contributor.authorCitil, Cihan
dc.contributor.authorKendir, Yalcin
dc.date.accessioned2026-10-18T20:30:39.299006576Z
dc.date.available2026-10-18T20:30:39.299006576Z
dc.date.issued2013
dc.description.abstractWe have investigated how diabetes affects the expression of adropin (ADR) in rat brain, cerebellum, kidneys, heart, liver, and pancreas tissues. The rats in the diabetic group were administered an intraperitoneal (i.p.) injection of a single dose of 60 mg/kg streptozotocin (STZ) dissolved in a 0.1 M phosphate-citrate buffer (pH 4.5). The rats were maintained in standard laboratory conditions in a temperature between 21 and 23 C and a relative humidity of 70 %, under a 12-h light/dark cycle. The animals were fed a standard commercial pellet diet. After 10 weeks, the animals were sacrified. ADR concentrations in the serum and tissue supernatants were measured by ELISA, and immunohistochemical staining was used to follow the expression of the hormones in the brain, cerebellum, kidneys, heart, liver, and pancreas tissues. The quantities were then compared. Increased ADR immunoreaction was seen in the brain, cerebellum, kidneys, heart, liver, and pancreas in the diabetes-induced rats compared to control subjects. ADR was detected in the brain (vascular area, pia mater, neuroglial cell, and neurons), cerebellum (neuroglial cells, Purkinje cells, vascular areas, and granular layer), kidneys (glomerulus, peritubular interstitial cells, and peritubular capillary endothelial cells), heart (endocardium, myocardium, and epicardium), liver (sinusoidal cells), and pancreas (serous acini). Its concentrations (based on mg/wet weight tissues) in these tissues were measured by using ELISA showed that the levels of ADR were higher in the diabetic rats compared to the control rats. Tissue ADR levels based on mg/wet weight tissues were as follows: Pancreas > liver > kidney > heart > brain > cerebellar tissues. Evidence is presented that shows ADR is expressed in various tissues in the rats and its levels increased in STZ-induced diabetes; however, this effect on the pathophysiology of the disorder remains to be understood. © 2013 Springer Science+Business Media New York.
dc.identifier.doi10.1007/s11010-013-1660-4
dc.identifier.eissn1573-4919
dc.identifier.endpage81
dc.identifier.issn1573-4919
dc.identifier.issue1-2
dc.identifier.pmid23620340
dc.identifier.scopus2-s2.0-84879799049
dc.identifier.startpage73
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/15807
dc.identifier.volume380
dc.identifier.wosWOS:000321131100008
dc.language.isoen
dc.publisherSPRINGER
dc.relation.ispartofMolecular and Cellular Biochemistry
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAdropin expression
dc.subjectImmunohistochemistry
dc.subjectRat tissues
dc.subjectSTZ-induced diabetes
dc.subjectAnimals
dc.subjectBrain
dc.subjectCerebellum
dc.subjectDiabetes Mellitus, Experimental
dc.subjectEnzyme-Linked Immunosorbent Assay
dc.subjectKidney
dc.subjectLiver
dc.subjectMale
dc.subjectMyocardium
dc.subjectPancreas
dc.subjectPeptides
dc.subjectRats
dc.subjectRats, Wistar
dc.subjectAnimalia
dc.subjectRattus
dc.subjectadropin
dc.subjectpeptide hormone
dc.subjectphosphate buffered saline
dc.subjectstreptozocin
dc.subjectunclassified drug
dc.subjectanimal cell
dc.subjectanimal experiment
dc.subjectanimal model
dc.subjectanimal tissue
dc.subjectarticle
dc.subjectbrain tissue
dc.titleExpression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus133
rdl.citation.wos137
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)